Why Most Foreign Healthcare Companies Quietly Fail in BrazilEven with distributors, competitive pricing, and ANVISA approval.
Because the real problem is rarely the product —
it's the structure behind the market entry.
For selected international healthcare companies evaluating or expanding in Brazil
If we met at Hospitalar, this is the next step. If not, this is what most companies miss before making critical decisions in Brazil.
Watch the Strategic Briefing
A concise executive overview explaining why most international healthcare companies struggle to scale in Brazil — even with distributors, ANVISA approval, and active operations.
Duration · 4.5 min
Limited capacity
Most companies leave Hospitalar with more questions than answers.
But the real risk isn't confusion.
It's leaving Brazil convinced you now understand the market…
When in reality, the most important structural risks are still invisible.
They believe they've found the right partners…
The right opportunities…
The right direction…
When in reality…
They are making decisions based on incomplete — and often misleading — signals.
And those decisions will define the next 12 to 36 months of their business in Brazil.
These sessions exist for one reason:
To help you separate real opportunity from costly illusion — before committing to the wrong structure.
The illusion
You can have everything in place.
And still fail.
ANVISA approval
Competitive pricing
A committed distributor
Not because of the market.
But because you're moving forward with confidence in the wrong conclusions.
The Invisible Problem
The Hidden Pattern Behind Most Failures in Brazil
Most companies don't fail because of regulation, taxes, or competition.
They fail because they rely on structures that appear commercially logical…
Signal progress…
But are fundamentally misaligned with how the Brazilian healthcare market actually operates.
The Pattern
The Distributor Savior Illusion™
A false sense of progress created when companies hand over control to a single partner — limiting visibility, access, and growth.
Authority
For over 25 years, our team has helped global companies successfully enter and scale in Brazil, including:
Recognized among
The 100 Most Influential in Healthcare in Brazil
Awarded as
Top 100 of the Decade — Brazilian Healthcare
As long-term commercial partners of Hospitalar — the leading healthcare trade show in Latin America —
our team operates at the intersection of global healthcare companies and the operational realities of the Brazilian market.
A New Category
A Different Way to Enter and Scale in Brazil
Companies that succeed in Brazil don't rely on assumptions. They build control into their market structure from the beginning.
The Method
Brazil Market Access
Control Architecture™
Product Registration
Market Access
Channel Strategy
Positioning
Execution
After Hospitalar
Most companies use Hospitalar to generate contacts.
Very few know how to transform those contacts into scalable market structure.
That's where costly mistakes usually begin.
These sessions were specifically designed for the critical strategic window immediately after Hospitalar —
when decisions are made quickly, but long-term consequences are rarely visible yet.
Choose Your Path
Choose the Strategic Path That Matches Your Current Position
New Entrants
Preparing to enter Brazil?
Learn how to avoid critical mistakes before they happen — and design an entry that compounds from day one.
- Pre-entry market diagnostic
- Distributor evaluation framework
- ANVISA & pricing strategy
Underperformers
Already in Brazil but not seeing results?
Identify what's blocking your growth — and rebuild the structure that will finally scale your operation.
- Operational structure audit
- Channel & partner re-architecture
- Growth unblock plan (90 days)
Privileged Access
This is not an open workshop.
These sessions are part of high-level strategic work typically delivered in private consulting engagements.
As part of our collaboration with Hospitalar, we've opened a limited number of seats for companies that are serious about operating and scaling in Brazil.
The Offer
Not workshops.
Strategic interventions.
These are not traditional workshops. They are strategic interventions designed to help international companies make clearer, faster, and safer strategic decisions in Brazil.
- ✓Avoid costly structural mistakes
- ✓Make better market decisions
- ✓Build a scalable presence in Brazil
- ✓Validate or correct your current direction before committing further
Qualification
Is this for you?
Fit
Who This Is For
- International healthcare companies preparing to enter Brazil
- Companies already operating in Brazil but underperforming
- Executives responsible for international expansion and business development
Not a Fit
Who This Is NOT For
- Companies looking for general or theoretical content
- Professionals without decision-making authority
- Businesses not committed to entering or growing in Brazil
In This Session
What you'll discover
Why distributors may be limiting your growth
The pricing mistake that makes your product invisible
Why ANVISA approval doesn't generate sales
How to evaluate if your partner is an asset or a bottleneck
How to build a structure that actually scales
Registrations traps and strategies to rush your market entry
The Math
In Brazil, a weak market structure rarely creates immediate failure.
Instead…
It silently compounds operational friction, dependency, lost visibility, and delayed growth over time.
Executive access investment
USD187*
Less than a single night of stay during Hospitalar Trade Show.
(*) Due to interaction, the number of participants is strictly limited.
These sessions are part of strategic frameworks typically delivered in private consulting engagements.
As part of our collaboration with Hospitalar, access has been made available for a limited number of participants.
Dates & Format
Upcoming Live Sessions
(Post-Hospitalar Strategic Window)
New Market Entrants
- Apply for this slot
📅 02 / June / 2026
🕒 10:00 UTC (7:00 AM Brasília)
- Apply for this slot
📅 03 / June / 2026
🕒 17:00 UTC (2:00 PM Brasília)
📍 Format: Live Online (Interactive Session with Q&A)
Underperforming Companies
- Apply for this slot
📅 02 / June / 2026
🕒 17:00 UTC (2:00 PM Brasília)
- Apply for this slot
📅 03 / June / 2026
🕒 10:00 UTC (7:00 AM Brasília)
📍 Format: Live Online (Interactive Session with Q&A)
These sessions are scheduled immediately after Hospitalar — when strategic decisions are being made and timing has the highest impact.
Timing & Capacity
Held only during key market moments — like Hospitalar — when timing has the highest impact.
Hospitalar
Strategic window
Limited
Interactive · spots strictly capped
Apply for your strategic session
Fix the structure first.
Then scale Brazil with clarity, control, and strategic alignment.
Choose the session that matches your stage and apply for your strategic session.
Limited Capacity
Beyond the Session
For selected companies requiring deeper strategic involvement… We may open the opportunity for continued advisory and execution support inside the Brazilian market.
Applying this architecture directly to your operation in Brazil.
Some of the companies we've worked with have turned early-stage efforts into multi-million dollar businesses in Brazil.
But it always starts the same way:
Fixing the structure first.
Selective continuation
Mentorship and execution partnership reserved for companies ready to deploy the architecture at scale.
FAQ
Frequently Asked Questions
Limited spots · Hospitalar